Zydus Lifesciences balance sheet

As of Mar 2026

Total assets: ₹52,407cr+40.9% on Mar 2025
Shareholders' equity: ₹29,582cr+12.2% on Mar 2025
Total debt: ₹11,770cr+271.3% on Mar 2025
Cash and investments: ₹6,631cr+16.8% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	9,231	6,042	5,803	5,697
	1,166	1,318	1,112	1,130
	7,543	5,242	5,266	4,804
	7,332	1,850	1,299	1,020
	2,533	1,374	1,312	70.5
	1,167	1,143	416	417
	598	414	552	511
	0.2	0.0	0.0	2.0
	34.4	40.9	179	498
	632	455	730	1,011
	2,109	2,344	1,644	1,262
	789	389	197	329
	32,501	20,156	17,779	15,740
	5,628	3,944	3,442	3,413
	5,776	4,851	253	619
	5,416	4,025	5,220	4,417
	855	827	413	488
	561	2,130	692	85.3
	3.7	77.1	1.5	0.4
	217	513	657	228
	12,829	12,423	7,237	5,838
	1,449	679	741	757
	19,906	17,046	11,420	10,008
	0.0	0.0	81.6	8.2
	52,407	37,202	29,281	25,756
Equity
	101	101	101	101
	27,011	23,853	19,729	17,415
	27,111	23,953	19,830	17,516
	2,471	2,405	2,272	2,173
	29,582	26,358	22,102	19,688
Liabilities
	3,188	0.0	0.0	0.0
	1,745	904	1,079	51.4
	4,933	904	1,079	51.4
	445	384	310	272
	1,734	513	447	194
	0.5	0.9	1.8	19.8
	7,113	1,802	1,837	537
	8,582	3,170	769	1,163
	2,845	2,306	2,127	2,125
	2,963	2,233	1,400	1,434
	14,389	7,708	4,295	4,722
	479	451	395	365
	366	616	372	157
	478	266	278	282
	15,712	9,042	5,340	5,527
	—	0.0	2.2	4.0
	22,824	10,843	7,179	6,068
	52,407	37,202	29,281	25,756
Trade payables — MSME split
	154	97.4	—	—
	2,691	2,208	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ZYDUSLIFE₹1,175.50

Zydus Lifesciences Ltd.

· Pharma & Health

₹ CrorePeersSUNPHARMA DRREDDY CIPLA TORNTPHARM DIVISLAB MAXHEALTH APOLLOHOSP AUROPHARMAMcap ₹1.18L Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	5,696.5	5,803.3	6,042.0	9,230.7	9,230.7
+ Capital Work-in-Progress	1,130.2	1,111.5	1,317.9	1,165.7	1,165.7
+ Goodwill	4,804.4	5,266.0	5,242.1	7,542.7	7,542.7
+ Other Intangibles	1,020.0	1,299.2	1,849.6	7,332.4	7,332.4
+ Intangibles under Development	70.5	1,311.8	1,374.0	2,532.8	2,532.8
+ Investments (Equity Method)	416.6	416.2	1,143.1	1,166.6	1,166.6
+ Non-current Investments	510.7	551.8	413.6	597.5	597.5
+ Long-term Loans	2.0	0.0	0.0	0.2	0.2
+ Other Non-current Financial Assets	498.0	178.5	40.9	34.4	34.4
Non-current Financial Assets	1,010.7	730.3	454.5	632.1	632.1
+ Deferred Tax Assets	1,262.4	1,644.2	2,343.8	2,108.6	2,108.6
+ Other Non-current Assets	328.7	196.9	388.6	788.9	788.9
Total Non-current Assets	15,740.0	17,779.4	20,155.6	32,500.5	32,500.5
Current Assets
+ Inventories	3,413.3	3,441.9	3,944.0	5,628.1	5,628.1
+ Current Investments	619.3	252.5	4,851.1	5,775.8	5,775.8
+ Trade Receivables	4,416.8	5,220.2	4,024.7	5,415.7	5,415.7
+ Cash & Cash Equivalents	487.8	413.0	826.8	855.2	855.2
+ Other Bank Balances	85.3	692.1	2,130.0	561.4	561.4
+ Short-term Loans	0.4	1.5	77.1	3.7	3.7
+ Other Current Financial Assets	228.0	657.3	513.0	216.9	216.9
Current Financial Assets	5,837.6	7,236.6	12,422.7	12,828.7	12,828.7
+ Other Current Assets	757.3	741.3	679.4	1,449.3	1,449.3
Total Current Assets	10,008.2	11,419.8	17,046.1	19,906.1	19,906.1
+ Assets Held for Sale	8.2	81.6	0.0	0.0	0.0
Total Assets	25,756.4	29,280.8	37,201.7	52,406.6	52,406.6
Equity
+ Equity Share Capital	101.2	100.6	100.6	100.6	100.6
+ Other Equity / Reserves	17,414.6	19,728.9	23,852.5	27,010.8	27,010.8
Equity — Owners of Parent	17,515.8	19,829.5	23,953.1	27,111.4	27,111.4
+ Minority Interest	2,172.5	2,272.1	2,405.3	2,470.8	2,470.8
Total Equity	19,688.3	22,101.6	26,358.4	29,582.2	29,582.2
Liabilities
+ Borrowings — Non-current	0.0	0.0	0.0	3,188.0	3,188.0
+ Other Non-current Financial Liab	51.4	1,079.3	904.3	1,744.7	1,744.7
Non-current Financial Liabilities	51.4	1,079.3	904.3	4,932.7	4,932.7
+ Provisions — Non-current	271.8	309.7	383.9	445.3	445.3
+ Deferred Tax Liabilities	194.4	446.5	512.6	1,734.0	1,734.0
+ Other Non-current Liabilities	19.8	1.8	0.9	0.5	0.5
Non-current Liabilities	537.4	1,837.3	1,801.7	7,112.5	7,112.5
+ Borrowings — Current	1,163.2	768.6	3,169.5	8,581.5	8,581.5
+ Trade Payables	2,125.0	2,126.7	2,305.8	2,845.1	2,845.1
+ Other Current Financial Liab	1,433.9	1,399.6	2,232.9	2,962.8	2,962.8
Current Financial Liabilities	4,722.1	4,294.9	7,708.2	14,389.4	14,389.4
+ Provisions — Current	365.4	394.8	451.4	478.5	478.5
+ Current Tax Liabilities	156.8	372.0	615.7	366.3	366.3
+ Other Current Liabilities	282.4	278.0	266.3	477.7	477.7
Current Liabilities	5,526.7	5,339.7	9,041.6	15,711.9	15,711.9
+ Liabilities Held for Sale	4.0	2.2	0.0	—	—
Total Liabilities	6,068.1	7,179.2	10,843.3	22,824.4	22,824.4
Total Equity & Liabilities	25,756.4	29,280.8	37,201.7	52,406.6	52,406.6
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	97.4	154.0	154.0
+ Dues to Other Creditors — Current	—	—	2,208.4	2,691.1	2,691.1

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.